Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers reach milestone in fight against lymphatic filariasis

05.12.2002


Four annual mass treatments of single doses of safe and inexpensive drugs found effective



Researchers report in the December 5 issue of the New England Journal of Medicine reaching an important milestone in learning how to halt a major mosquito-borne disease affecting 120 million people around the world. The disease, called lymphatic filariasis and commonly known as elephantiasis, is a leading cause of physical disfigurement, social ostracism, and economic loss throughout Africa, Asia, South America, and islands of the Pacific Ocean. The disease can lead to dramatically swollen and disfigured legs, arms, breasts, and genitals.

Treating 2500 residents in a remote area of Papua New Guinea in the South Pacific, the researchers from Case Western Reserve University School of Medicine, University Hospitals of Cleveland, and Papua New Guinea Institute of Medical Research found dramatic results with four annual mass treatments of single doses of safe and inexpensive anti-filarial (anti-worm) drugs. There was a greater than 95 percent decrease in mosquito transmission, nearly complete prevention of new infections in children, reduction of infection rates in the communities to less than one percent, and remarkably, cure of severe disease manifestations such as extremely enlarged arms and legs, and genital disfigurement. Combined with conclusions drawn from mathematical analysis of the interrelationships between the potentials of mosquito transmission and human infection, the report clearly sets the precedent that annual mass treatment with safe and inexpensive medications can go a long way toward eliminating this devastating disease.


James W. Kazura, M.D., the paper’s senior author, notes that this work represents an important milestone in the world-wide effort to combat filariasis. "Until this study, it was not clear that eradication and significant decreases in mosquito-borne transmission and disease severity could be realized even on a small scale." Kazura is a professor of medicine at CWRU and UHC.

Lymphatic filariasis is caused by microscopic juvenile parasitic worms that are transmitted to humans by mosquitoes containing these infective parasites. The juvenile parasites migrate from the site of the mosquito bite and ultimately develop into adult worms in the lymphatic system of the human host, where they cause the hallmark inflammation of filariasis. In many rural areas of Papua New Guinea, Africa, and India, nearly 10 percent of persons suffer from elephantiasis by adulthood, and large numbers of men develop such swelling of the scrotum that it can reach the size of a grapefruit. Transmission is continued in nature when the microscopic offspring of adult worms, called microfilariae, circulate in the bloodstream and are subsequently ingested by blood-feeding mosquitoes. After further development in the mosquito, the parasites are capable of infecting humans when the insect takes its next blood meal.

Building on more than 20 years of research and clinical investigations on filariasis, the project was conducted in Papua New Guinea, where transmission of filariasis and other serious infectious diseases such as malaria reach the highest levels seen anywhere in the world.

"Performance of a study in this setting to determine whether inexpensive and safe medications could decrease transmission of filariasis and control its clinical outcomes represents an extraordinarily tough test or ’proof of principle’ of the Global Plan to Eradicate Lymphatic Filariasis," says Kazura. "This plan, officially launched by the World Health Assembly in Geneva in 1997, states that filariasis is one of six diseases that is potentially eradicable. The target date to achieve this goal at a global level has been set at 2020. With support from the Bill and Melinda Gates Foundation and other non-governmental philanthropic organizations, administration by the Global Alliance through the Carter Center in Atlanta and World Health Organization, and donation of anti-filarial drugs by GlaxoSmithKline and Merck Pharmaceuticals, the infrastructure to implement the control plan in Africa, Latin America, Asia, and Pacific island nations has been growing over the past several years.

"This study provides essential guidelines to control this infectious disease and points the way to the ultimate eradication of filariasis on a global level," says Kazura.

"The work also poses interesting and challenging new research questions that should enable the testing of new hypotheses on how genetics and immunity determine infection susceptibility in humans and contribute to the development and ultimately prevention of lymphatic disease," he says.

An accompanying editorial written by Eric A. Ottesen, M.D., of Emory University, says this study has yielded important conclusions. "It should serve as a touchstone for future evaluations of other programs, both inside and outside the research community," it states.

George Stamatis | EurekAlert!
Further information:
http://www.cwru.edu/

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

New materials: Growing polymer pelts

19.11.2018 | Materials Sciences

Earthquake researchers finalists for supercomputing prize

19.11.2018 | Information Technology

Controlling organ growth with light

19.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>